Clinical Trial Update: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating temsirolimus in combination with dexamethasone for recurrent or refractory multiple myeloma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Torisel (Temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma | Phase 1 | Status: COMPLETED